Veeva Systems (NYSE:VEEV) Given New $310.00 Price Target at Guggenheim

Key Points

• Guggenheim raised Veeva Systems’ price target to $310 from $276 and maintained a “buy” rating, implying roughly 5.15% upside from the prior close. Analysts overall assign the stock a “Moderate Buy” consensus rating with a $264 average target.
• Veeva reported strong fiscal second-quarter results, with revenue rising 17.6% year over year to $928 million and EPS of $2.35 beating the $2.22 consensus. Its quarterly and full-year guidance also came in above analyst expectations.
• The stock has gained sharply and trades near its 12-month high, but its elevated valuation leaves less room for execution disappointments. Institutional investors own 88.2% of shares, while an insider recently sold 36,000 shares under a pre-arranged trading plan.

Veeva Systems (NYSE:VEEV - Get Free Report) had its price objective boosted by Guggenheim from $276.00 to $310.00 in a research note issued on Thursday,Benzinga reports. The brokerage presently has a "buy" rating on the technology company's stock. Guggenheim's price objective indicates a potential upside of 5.15% from the company's previous close.

Other analysts have also issued research reports about the company. BMO Capital Markets lowered their price target on Veeva Systems from $220.00 to $175.00 and set a "market perform" rating for the company in a report on Thursday, June 4th. TD Cowen reaffirmed a "buy" rating on shares of Veeva Systems in a research report on Monday. Wall Street Zen lowered shares of Veeva Systems from a "buy" rating to a "hold" rating in a research report on Monday, August 3rd. The Goldman Sachs Group lowered their price objective on shares of Veeva Systems from $190.00 to $165.00 and set a "sell" rating on the stock in a research note on Thursday, June 4th. Finally, Oppenheimer lifted their target price on shares of Veeva Systems from $225.00 to $300.00 and gave the stock an "outperform" rating in a research report on Monday, August 17th. Nineteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $264.00.

Veeva Systems Trading Up 20.4%

NYSE VEEV opened at $294.82 on Thursday. The company's 50-day moving average price is $203.41 and its 200-day moving average price is $183.04. The stock has a market cap of $47.89 billion, a PE ratio of 51.94, a PEG ratio of 1.06 and a beta of 0.92. Veeva Systems has a 12 month low of $148.05 and a 12 month high of $310.50.

Veeva Systems (NYSE:VEEV - Get Free Report) last announced its quarterly earnings data on Wednesday, August 26th. The technology company reported $2.35 earnings per share for the quarter, beating analysts' consensus estimates of $2.22 by $0.13. The company had revenue of $927.96 million during the quarter, compared to analyst estimates of $905.38 million. Veeva Systems had a net margin of 28.37% and a return on equity of 13.72%. The firm's revenue for the quarter was up 17.6% on a year-over-year basis. During the same quarter last year, the business posted $1.99 EPS. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. As a group, sell-side analysts forecast that Veeva Systems will post 6.65 earnings per share for the current year.

Insider Activity at Veeva Systems

In related news, insider Thomas D. Schwenger sold 36,000 shares of Veeva Systems stock in a transaction dated Thursday, August 13th. The stock was sold at an average price of $250.23, for a total transaction of $9,008,280.00. Following the completion of the sale, the insider owned 19,449 shares in the company, valued at approximately $4,866,723.27. This trade represents a 64.92% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. California State Teachers Retirement System raised its position in shares of Veeva Systems by 16,590.3% in the second quarter. California State Teachers Retirement System now owns 39,388,224 shares of the technology company's stock valued at $6,990,228,000 after buying an additional 39,152,230 shares during the last quarter. Principal Financial Group Inc. boosted its holdings in shares of Veeva Systems by 7.0% during the first quarter. Principal Financial Group Inc. now owns 4,141,545 shares of the technology company's stock worth $727,513,000 after purchasing an additional 271,252 shares during the last quarter. State Street Corp grew its position in shares of Veeva Systems by 2.4% in the fourth quarter. State Street Corp now owns 3,589,425 shares of the technology company's stock valued at $801,267,000 after purchasing an additional 85,695 shares during the period. Geode Capital Management LLC increased its stake in Veeva Systems by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 3,172,716 shares of the technology company's stock valued at $706,442,000 after purchasing an additional 23,117 shares during the last quarter. Finally, AQR Capital Management LLC increased its stake in Veeva Systems by 31.2% in the third quarter. AQR Capital Management LLC now owns 2,412,210 shares of the technology company's stock valued at $706,078,000 after purchasing an additional 574,164 shares during the last quarter. 88.20% of the stock is currently owned by hedge funds and other institutional investors.

Veeva Systems News Roundup

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva reported fiscal Q2 revenue of $928.0 million, up 17.6% year over year, while EPS of $2.35 exceeded the $2.22 analyst consensus. Subscription revenue increased 16% to $766.8 million. Veeva Announces Fiscal 2027 Second Quarter Results
• Positive Sentiment: Management issued fiscal Q3 revenue guidance of approximately $932 million-$935 million and EPS guidance of $2.33-$2.34, both above Wall Street expectations. Full-year fiscal 2027 EPS guidance of $9.21 and revenue guidance of about $3.7 billion also exceeded consensus estimates. Veeva Q2 2027 Earnings Call Transcript
• Positive Sentiment: Executives highlighted continued strength in Vault CRM, targeting more than 70% market share, and said the first Falcon customer deployments are expected this year. AI-related capabilities are also contributing to demand and revenue growth. Veeva CRM and Falcon Update
• Positive Sentiment: Needham reaffirmed its Buy rating, while Piper Sandler initiated coverage, adding favorable analyst attention following the earnings release. Needham Reaffirms Buy Rating
• Neutral Sentiment: Analyst commentary emphasized Veeva’s combination of recurring growth, strong margins and financial strength, but the stock’s elevated valuation—around 44 times earnings—leaves less room for execution or guidance disappointments.
• Negative Sentiment: The modest decline in the shares despite the earnings and guidance beats suggests investors may be taking profits or were already pricing in strong results. Near-term sentiment could remain sensitive to valuation and the pace of new product adoption.

Veeva Systems Company Profile

Veeva Systems NYSE: VEEV is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva's product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source